Medical Care Technologies (OTC PINK:MDCE) Initiates Preparatory Phase for Self-Conducted Research Studies on AI Mental Health and Preventive Biometrics Modules
Medical Care Technologies (OTC PINK:MDCE) announced on October 8, 2025 that it is beginning preparatory, internal non-clinical research on two consumer AI modules: the Mental Health & Micro-Expression Tracker and the Preventive Health & Facial Biometrics Analyzer. The studies will be self-conducted by MDCE's Consumer AI Division to test algorithmic performance, consistency, and data reliability in real-world conditions.
The Tracker uses facial landmarking and emotion-recognition networks to monitor subtle stress and focus shifts; the Biometrics Analyzer uses colorimetric and vascular mapping to evaluate visible wellness indicators. Results are intended for internal model refinement and to support future wellness-research collaborations. The company emphasized accuracy, transparency, and that these tools are for self-monitoring rather than clinical diagnosis.
Medical Care Technologies (OTC PINK:MDCE) ha annunciato l'8 ottobre 2025 che sta per avviare ricerche interne preparatorie non cliniche su due moduli di IA per i consumatori: il Mental Health & Micro-Expression Tracker e l'Preventive Health & Facial Biometrics Analyzer. Gli studi saranno condotti autonomamente dalla Divisione IA per i Consumatori di MDCE per testare le prestazioni degli algoritmi, la coerenza e l'affidabilità dei dati in condizioni reali.
Il Tracker utilizza l'annotazione delle caratteristiche facciali e reti di riconoscimento delle emozioni per monitorare sottili variazioni di stress e concentrazione; l'Analizzatore Biometrics impiega mapping colorimetrico e vascolare per valutare indicatori visibili di benessere. I risultati sono destinati a rifinire internamente i modelli e a supportare future collaborazioni di ricerca sul benessere. L'azienda ha sottolineato l'accuratezza, la trasparenza e che questi strumenti sono destinati all'auto-monitoraggio piuttosto che a una diagnosi clinica.
Medical Care Technologies (OTC PINK:MDCE) anunció el 8 de octubre de 2025 que iniciará investigaciones internas preparatorias no clínicas sobre dos módulos de IA para consumidores: el Mental Health & Micro-Expression Tracker y el Preventive Health & Facial Biometrics Analyzer. Los estudios serán llevados a cabo de forma autónoma por la División de IA para Consumidores de MDCE para probar el rendimiento de los algoritmos, la consistencia y la fiabilidad de los datos en condiciones reales.
El Tracker utiliza el reconocimiento de rasgos faciales y redes de reconocimiento de emociones para monitorizar cambios sutiles de estrés y enfoque; el Biometrics Analyzer utiliza mapeo colorimétrico y vascular para evaluar indicadores visibles de bienestar. Se pretende que los resultados sirvan para la mejora interna de los modelos y para apoyar futuras colaboraciones de investigación sobre bienestar. La empresa enfatizó la precisión, la transparencia y que estas herramientas son para automonitoreo y no para diagnóstico clínico.
Medical Care Technologies (OTC PINK:MDCE)는 2025년 10월 8일에 소비자용 인공지능 모듈 두 가지에 대한 예비의 내부 비임상 연구를 시작한다고 발표했습니다: Mental Health & Micro-Expression Tracker와 Preventive Health & Facial Biometrics Analyzer. 이 연구들은 MDCE의 Consumer AI Division이 자가 수행하여 알고리즘의 성능, 일관성, 데이터 신뢰성을 실제 환경에서 테스트할 예정입니다.
Tracker는 얼굴 특징지정과 감정 인식 네트를 사용하여 미세한 스트레스와 집중 변화을 모니터링하고, Biometrics Analyzer는 색도 매핑과 혈관 매핑을 이용해 가시적인 건강 지표를 평가합니다. 결과는 내부 모델 개선과 향후 웰빙 연구 협력에 활용될 예정입니다. 회사는 정확성, 투명성 및 이 도구들이 임상 진단이 아니라 자가 모니터링을 위한 것임을 강조했습니다.
Medical Care Technologies (OTC PINK:MDCE) a annoncé le 8 octobre 2025 qu'elle entame des recherches internes préparatoires non cliniques sur deux modules IA destinés aux consommateurs : le Mental Health & Micro-Expression Tracker et le Preventive Health & Facial Biometrics Analyzer. Les études seront menées en interne par la Division IA Consommateurs de MDCE afin de tester les performances des algorithmes, la cohérence et la fiabilité des données dans des conditions réelles.
Le Tracker utilise des repères faciaux et des réseaux de reconnaissance des émotions pour surveiller des variations subtiles de stress et de concentration ; le Biometrics Analyzer utilise une cartographie colorimétrique et vasculaire pour évaluer des indicateurs visibles de bien-être. Les résultats sont destinés à affiner les modèles en interne et à soutenir de futures collaborations de recherche sur le bien-être. L'entreprise a mis l'accent sur l'exactitude, la transparence et sur le fait que ces outils sont destinés à l'auto-surveillance plutôt qu'à un diagnostic clinique.
Medical Care Technologies (OTC PINK:MDCE) gab am 8. Oktober 2025 bekannt, dass es mit vorbereitenden internen Nichtrisikostudien an zwei Verbraucher-AI-Modulen beginnt: dem Mental Health & Micro-Expression Tracker und dem Preventive Health & Facial Biometrics Analyzer. Die Studien werden eigenständig von der MDCE Consumer AI Division durchgeführt, um die Algorithmusleistung, Konsistenz und Datenzuverlässigkeit unter realen Bedingungen zu testen.
Der Tracker verwendet Facial Landmarking und Emotions-Erkennungsnetzwerke, um subtile Stress- und Fokusveränderungen zu überwachen; der Biometrics Analyzer nutzt farbmetrische und vaskuläre Abbildungen, um sichtbare Gesundheitsindikatoren zu bewerten. Ergebnisse sollen intern zur Modellverfeinerung dienen und zukünftige Wellness-Forschungskooperationen unterstützen. Das Unternehmen betonte Genauigkeit, Transparenz und dass diese Werkzeuge der Selbstüberwachung dienen und keine klinische Diagnose ersetzen.
Medical Care Technologies (OTC PINK:MDCE) أعلنت في 8 أكتوبر 2025 أنها ستبدأ أبحاثاً تحضيرية داخلية غير إكلينيكية عن وحدتي ذكاء صناعي للمستهلكين: مراقب الصحة العقلية والتعبير المجهري والمحلل الصحي الوقائي والبيانات الحيوية للوجه. ستجريها قسم الذكاء الاصطناعي للمستهلكين بشركة MDCE بشكل مستقل لاختبار أداء الخوارزميات وتناسق البيانات وموثوقيتها في ظروف العالم الحقيقي.
يستخدم المراقب اكتشاف المعالم الوجهية وشبكات تعرف العواطف لمراقبة تغييرات دقيقة في الإجهاد والتركيز؛ ويستخدم المحلل الحيوي البصري قياس الألوان وتخطيط الوعيات لتقييم مؤشرات الرفاه المرئية. من المفترض أن تكون النتائج لتطوير النماذج داخلياً ودعم تعاونات أبحاث الرفاه المستقبلية. أكدت الشركة الدقة والشفافية وأن هذه الأدوات هي للمراقبة الذاتية وليست تشخيصاً سريرياً.
Medical Care Technologies (OTC PINK:MDCE) 于 2025年10月8日宣布开始对两个人群AI模块进行准备阶段的内部非临床研究：心理健康与微表情追踪器与预防性健康与面部生物识别分析器。这些研究将由MDCE的消费者AI部门自行开展，以在真实世界条件下测试算法性能、一致性和数据可靠性。
追踪器使用面部地标与情感识别网络来监测微妙的压力和专注度变化；生物识别分析器通过比色和血管映射来评估可见的健康指标。结果旨在内部用于模型改进并支持未来的健康研究合作。公司强调准确性、透明度，以及这些工具是用于自我监测而非临床诊断。
- None.
- None.
MESA, ARIZONA / ACCESS Newswire / October 8, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), an emerging innovator in AI-powered preventive healthcare, announced that it is preparing to conduct internal, non-clinical research studies on the consumer-facing components of its AI health platform - the Mental Health & Micro-Expression Tracker and the Preventive Health & Facial Biometrics Analyzer.
These studies are part of the company's Consumer AI Division, which focuses on self-monitoring, behavioral research, and preventive awareness rather than clinical diagnosis. Both modules extend MDCE's broader vision of combining facial, ocular, and skin imaging analytics to forecast early health changes through accessible, camera-based AI tools.
Research Overview:
The Mental Health & Micro-Expression Tracker uses advanced facial landmark tracking and emotion-recognition networks to observe subtle shifts in stress, focus, and emotional balance.
The Preventive Health & Facial Biometrics Analyzer applies colorimetric and vascular mapping algorithms to evaluate visible wellness indicators such as tone, elasticity, and fatigue.
Both will undergo self-conducted algorithmic testing to assess performance consistency and data reliability under diverse real-world conditions. Results will be used internally to refine MDCE's AI models and support future wellness-research collaborations.
"Our goal is to ensure that every module - clinical or consumer - meets a measurable standard of accuracy and transparency," said CEO Marshall Perkins III. "These studies demonstrate our commitment to technical rigor and responsible AI development across all health verticals."
Forward-Looking Statements / Safe Harbor
This release includes forward-looking statements regarding future research activities and product development. Actual results may differ due to technical, regulatory, or operational variables. Medical Care Technologies Inc. assumes no obligation to update such statements.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC Pink:MDCE) develops AI-based imaging systems that combine facial, ocular, and dermatological analytics to advance predictive and preventive healthcare. Its modular platform includes both FDA-eligible clinical applications and consumer-focused research tools.
Visit www.medicalcaretechnologies.com for more information.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
FAQ
What studies did MDCE announce on October 8, 2025 for OTC PINK:MDCE?
How will MDCE test the Mental Health & Micro-Expression Tracker (MDCE)?
Will MDCE’s biometric modules be used for clinical diagnosis?
What does the MDCE announcement mean for shareholders in the near term?
How will MDCE use results from the October 2025 consumer AI studies?
Are there regulatory or clinical approvals described in MDCE’s October 8, 2025 release?
